Baseline characteristics of study population
| Categorical variables and usage of drugs at baseline | ||
|---|---|---|
| Sex | ||
| Male | 3589 | 45% |
| Female | 4336 | 55% |
| Blood glucose lowering drug | ||
| No | 7637 | 96% |
| Yes | 288 | 4% |
| Insulin | ||
| No | 7787 | 98% |
| Yes | 138 | 2% |
| Antithrombotic agent | ||
| No | 7582 | 96% |
| Yes | 343 | 4% |
| Antiplatelet agent | ||
| No | 7764 | 98% |
| Yes | 161 | 2% |
| Vitamin K antagonists | ||
| No | 7732 | 98% |
| Yes | 193 | 2% |
| Continuous variables at baseline LDL cholesterol (mmol/L) | ||||||
|---|---|---|---|---|---|---|
| 1st Qu | Median | Mean | 3rd Qu | SD | Missing | |
| Age | 42.0 | 52.0 | 54.7 | 66.0 | 16.1 | 0 |
| Blood glucose (mmol/L) | 5.0 | 5.3 | 5.6 | 5.7 | 1.3 | 1275 |
| Total cholesterol (mmol/L) | 5.1 | 5.9 | 5.9 | 6.6 | 1.1 | 1275 |
| HDL cholesterol (mmol/L) | 1.1 | 1.3 | 1.3 | 1.6 | 0.4 | 1275 |
| LDL cholesterol (mmol/L) | 3.1 | 3.8 | 3.8 | 4.5 | 1.2 | 1276 |
| Triglycerides (mmol/L) | 1.0 | 1.3 | 1.6 | 1.9 | 1.1 | 1275 |
| Ratio HDL/cholesterol | 18.0 | 22.0 | 23.0 | 28.0 | 7.4 | 1275 |
| CRP (mg/L) | 0.3 | 0.8 | 2.3 | 2.0 | 6.3 | 1694 |
| Vitamin D3 (nmol/L) | 33.0 | 43.0 | 44.9 | 55.0 | 16.9 | 1825 |
| Homocysteine (µmol/L) | 9.2 | 11.0 | 12.0 | 13.5 | 5.1 | 1825 |
| Insulin (mU/L) | 5.0 | 7.0 | 9.6 | 11.0 | 30.3 | 1627 |
CRP, C reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Qu, quartile.